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Abstract  
Significant amount of research efforts have been dedicated to the development of scaffolds for 
tissue engineering. Although, at present most of the studies are focused on non-load bearing 
scaffolds, many scaffolds have also been investigated for hard tissue repair. In particular, 
metallic scaffolds are being studied for hard tissue engineering due to their suitable mechanical 
properties. Several biocompatible metallic materials such as stainless steels, cobalt alloys, 
titanium alloys, tantalum, nitinol and magnesium alloys have been commonly employed as 
implants in orthopedic and dental treatments. They are often used to replace and regenerate the 
damaged bones or to provide structural support for healing bone defects. Among the metal 
implants, magnesium (Mg) and a number of its alloys are effective because of; their mechanical 
properties close to those of human bone, their natural ionic content that has important functional 
roles in physiological systems, and their in vivo biodegradation characteristics in body fluids. 
Due to such collective properties, Mg based alloys can be employed as biocompatible, bioactive, 
and biodegradable scaffolds for load-bearing applications. Recently, porous Mg and Mg alloys 
have been specially suggested as metallic scaffolds for bone tissue engineering. With further 
optimization of the fabrication techniques, porous Mg is expected to make a promising hard 
substitute scaffold. The present review covers research conducted on the fabrication techniques, 
surface modifications, properties and biological characteristics of Mg alloys. Furthermore, the 
potential applications, challenges and future trends of Mg scaffolds are discussed in detail. 
Keywords: Magnesium; Porous Scaffolds, Biodegradation, Bone, Cartilage 
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1. Introduction  
There are wide variety of biocompatible materials used for different orthopaedic applications.  
Among them, metallic biomaterials have been specifically utilized to produce an assortment of 
orthopaedic implants such as the head of the femoral component of a total hip joint replacement 
(THJR), the tibial tray in a total knee joint replacement (TKJR), the stem of the total shoulder 
joint replacement, and the spinal fusion cage [1, 2]. Biodegradable metals are a relatively new 
class of biodegradable materials that degrade slowly in the body with a suitable host reaction 
elicited by the released degradation products. The biodegradable metal should disappear entirely 
upon fulfilling the mission of supporting the tissue regeneration leaving no implant residues; 
hence, no further surgical operation is needed for the implant removal [3]. 
Appropriate biocompatibility, low in vivo corrosion rate and high strength are the main 
parameters for the selection of a metal for the mentioned applications [4]. The principal issue of 
metallic implants is their loosening due to bone resorption caused by stress shielding, weak 
interfacial bonding between the implant and the bone, and the lack of biological anchorage for 
the growing tissue [2]. To address these issues, there has been much effort on the development 
and characterization of metal implants with microstructures and properties close to those of 
trabecular bone. Accordingly, these materials are called open-cell porous metals, metallic foams, 
metallic scaffolds, or cellular metals with three-dimensional interconnected pores. The pore sizes 
are typically between 200 and 500 µm with total porosity of 50±75% [5].  
The stability of an implant is mainly dependent on both its mechanical strength and its fixation 
ability to the host tissue. In the past, such stability was mostly achieved by means of pins, screws 
and bone cements [6]. However, in recent experiments, researchers are attempting to improve the 
fixation by tissue engineering techniques [7]. For this purpose, the metal is made porous to 
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provide a scaffold for the bone tissue to grow into and through the pores thus making a suitable 
bond to the metallic implant [8]. Present tissue engineering approaches are focused on the 
development of porous scaffolds made of different biomaterials with the aim of replacing and 
restoring the pathologically altered tissues by transplantation of the cells [9, 10]. Such scaffolds 
for engineering of hard tissues need suitable mechanical integrity [11]. A porous 3D material 
provides the required pathways for cells to grow, proliferate, and differentiate, while the 
architecture defines the final structure of the newly formed bone [12-15]. It is worth mentioning 
that the spontaneous renewal of the bone is restricted to only small defects. The treatment of 
large bone segments caused by tumors, trauma, implant failure, or osteitis is far more 
challenging to be addressed. An ideal bone tissue engineering scaffold must be biocompatible, 
osteoconductive, and biodegradable, with a high mechanical strength to fulfil the necessary load-
bearing functions [8]. Also, it must have interconnected porous networks allowing cell 
migration, vascularization and nutrient delivery [16]. The challenge to achieve the 
abovementioned properties in existent scaffolds, has made bone tissue engineering a very 
popular research field in the last decade in regards to the material selections and production 
techniques [13, 17]. Although, porosity is necessary for scaffolds, it considerably reduces the 
scaffoOG¶V VWUHQJWK ZKLFK LV YLWDO LQ SDUWLFXODU IRU ODUJH ERQH GHIHFWV [18, 19]. The trade-off 
between the mechanical strength and the porosity is one of the main challenges in designing 
tissue engineered bone scaffolds [6]. At present, various types of biomaterials have been 
employed for this aim, which are synthetic or naturally-derived. 
2. Advantages and disadvantages of the porous magnesium-based scaffold compared to 
other scaffolds 
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Early 1970s was the starting date for investigations on porous biomaterials such as ceramic [20], 
polymeric [21], and metallic materials [22], which identified several promising selections for 
porous implants that would allow bone in-growth. Although ceramics have shown outstanding 
corrosion properties, their inherent brittleness makes them difficult to be used for load bearing 
applications [16]. Porous polymeric scaffolds cannot resist the high mechanical stresses present 
in bone replacement operations [16]. This has led researchers to study porous metals, based on 
orthopaedic metallic implants, due to their greater compressive strength, fracture toughness, and 
fatigue resistance, which are needed for load-bearing applications [6, 16]. Due to the excellent 
physical and mechanical properties of magnesium compared to other permanent (non-
degradable) metals, porous magnesium and Mg alloys became a good candidate to serve as a 
biodegradable scaffold for bone treatments [23, 24]. 
Among the metal implants, Mg and a number of its alloys are effective because of 1) their 
mechanical properties which are close to those of human bone, 2) their natural ionic content that 
has important functional roles in physiological systems, and 3) their in vivo biodegradation 
characteristics in body fluids. Some physical properties of the Mg alloys, such as high specific 
strength and elastic modulus, are closer to those of the natural human bone compared to other 
traditional metal implants [27, 28]. For example, compared to titanium alloys with the elastic 
modulus of 110±117 GPa, Mg alloys have lower modulus (41±45 GPa) leading to a decreased 
stress-shielding effect [29, 30]. Moreover, Mg alloys are 3±16 times stronger than biopolymers 
and, at the same time, they are more ductile compared to bioceramics, which can reduce the 
chance of the device fracturing throughout the implantation process. Moreover, compared to 
polymers, Mg alloys can encourage bone growth, which can help the implant to be properly 
fixed with the host bone to potentially allow full healing of bone defects after degradation [31, 
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32]. Mg is an essential ion in metabolism and its deficiency in the body may cause some 
pathological conditions. Due to such collective properties, Mg based alloys can be employed as 
biocompatible, bioactive, and biodegradable scaffolds for load-bearing biomedical applications 
[25, 26]. Such characteristics encourage employing biodegradable Mg and Mg alloys as 
lightweight metals for load bearing orthopaedic implants, which would remain in the body and 
keep mechanical stability over a time scale of 3-4 months, while the natural bone tissue heals 
[33, 34]. 
The main challenge for employing Mg and its alloys as an implant is its high corrosion rate 
resulting in the rapid release of degradation products in the body [35, 36]. The low corrosion 
resistance in physiological environments can have an adverse effect on the mechanical stability 
of the implant prior to bone healing [37]. Mg¶VORZFRUURVLRQUHVLVWDQFHDOVROHDGVWRWKHUDSLG
release of hydrogen gas and the formation of subcutaneous gas pockets close to the implant. 
These side products would collect around the implant and interrupt the tissue healing [38, 39]. In 
addition, due to the hydrogen release, a local alkalization occurs around the implant, which 
affects the pH-dependent physiological processes in the surrounding area of the implant [17]. 
The need for relatively low corrosion resistance property, makes it necessary to take relevant 
measures to control its high corrosion rate [40]. This review aims to bring together recent studies 
on Mg and Mg alloys scaffolds with regards to production techniques, surface modifications, 
general properties, potential applications and future trends. If Mg scaffolds with the proper 
mechanical and corrosion properties can be successfully applied in bone defect treatments, a 
second operation process for the implant removal will be avoided; which in turn will aid the bone 
healing,  minimize the trauma to the patients, and decrease the medical costs [41]. 
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2. Design and production methods 
2.1. Titanium wire space holder  
A novel technique for the production of magnesium scaffolds using titanium wires as space 
holder has been recently developed by Jiang et. al. [42]. This technique includes three steps: (a) 
An entangled three-dimensional shape is made of titanium wire [43], (b) the prepared titanium 
pattern is utilized as a space holder to generate a titanium/magnesium hybrid system by 
infiltrating the magnesium cast, and (c) the titanium space holder is dissolved from the hybrid 
system by hydrofluoric acid (HF) etching at room temperature [42]. With this approach, it is 
feasible to formulate porous magnesium scaffolds with adjustable pore size and structure [42]. 
Figure 1 schematically demonstrates the abovementioned stages[42]. Similar to the shape and 
dimension of titanium wires, the pores in the magnesium scaffold consist of channels with pipe-
OLNH VWUXFWXUHV ZLWK GLDPHWHU RI DSSUR[LPDWHO\  ȝP 7KH UHVXOWV RI PHFKDQLFDO WHVWV KDV
shown that the produced magnesium scaffolds with porosities of 54.2%, 51% and 43.2% had 
elastic modulus of 0.5, 0.6 and 1.0 GPa, and compressive yield strengths of 4.3, 4.6 and 6.2 MPa, 
respectively. Such results are comparable to the mechanical properties of natural bone, and thus 
offer potential applications in the treatment of bone defects [42].  
 
2.2. Negative salt pattern molding 
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Kirkland et al. [44] have developed a new multistep technique with the aim of production of an 
ordered open cell porous Mg scaffold with controllable porosity and microstructure by a rapid 
prototyping and casting method. For this purpose, as a supersaturated paste, salt particles were 
made with high purity (99.5%). Computer-aided design (CAD) models were then engineered as a 
positive pattern by 3D printing of an acrylic polymer infiltrated in a specific salt slurry. Entire 
elimination of the polymer by combustion in air using a burnout cycle led to formation of a 
negative salt pattern which was then infiltrated with melted Mg. Following Mg solidification, the 
salt was dissolved by washing in NaOH solution. Similar to the macroscopic shapes of the CAD 
models, a porous Mg scaffold with ordered pores was formed after removal of the salt template 
by solvent washing. A schematic picture of the entire process is illustrated in figure 2 [44]. This 
research indicates that successful manufacture of topologically ordered porous salt patterns 
facilitated the negative replication of the ordered three-dimensional configuration utilizing pure 
Mg [44]. 
An in vivo study was also carried out on open porous Mg scaffolds which had been produced by 
a negative salt pattern molding process on biodegradable AZ91D alloy [45]. In this study, a 
negative template was prepared by pouring the moistened NaCl particles into a core box. The salt 
template was then infiltrated by Mg melt in a die casting system and the salt particles were then 
washed out by the NaOH solution. This technique resulted in a scaffold with 72-76% porosity 
and a pore size distribution of 10±1000 µm [45]. The produced Mg scaffold was implanted into 
the right knee and an autologous bone graft from the left patellar groove was implanted into the 
left knee as a control group. Mg scaffolds were significantly corroded after 3 months, and most 
of the implanted Mg alloy was degraded. These findings confirms that even rapid corroding Mg 
scaffold has reliable biocompatibility with a desirable inflammatory host response in vivo [45]. 
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2.3. Powder metallurgy 
Porous Mg scaffolds can be prepared using a powder metallurgy process by mixing the Mg 
powder and space holder agents. Normally, a two-step heat treatment is required in order to burn 
out the space holder agents as well as a sintering process on the pressed powder. Seyedraoufi et 
al. [46] produced a Mg-Zn alloy scaffold  by blending and pressing Mg, 4wt% Zn and 6wt% Zn 
powders with carbamide (CO(NH2)2, 15%, 25% and 35% volume contents) with the particle size 
of 200±400 µm. The blended powders were pressed at 100 MPa pressure followed by a two-step 
heat treatment. The first step was adjusted to remove the carbamide particles by heating up to 
250 °C for 4 h. The second step involved the sintering process, by heating up to 500, 550, 565 
and 580 °C for 2 h. This study found a relationship between the mechanical properties and the 
porosity content 7KH FRPSUHVVLYH VWUHQJWK DQG <RXQJ¶V PRGXOXV RI WKH 0J-Zn scaffolds 
decreased with increment in porosities at all sintering temperatures. Moreover, the temperature 
of 550 °C was introduced as the optimum condition for the sintering process since the highest 
FRPSUHVVLYHVWUHQJWKDQG<RXQJ¶VPRGXOXVwell obtained at this temperature. The results of this 
study confirmed that the produced Mg±Zn scaffolds with 21±36% porosity could have superior 
mechanical properties comparable with that of cancellous bone [46]. 
An example of an open porous magnesium scaffold with interconnected pore microstructure 
produced by powder metallurgy for orthopedic applications is shown in figure 3,  reproduced 
from the work of Yazdimamaghani  et al. [47]. 
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The main disadvantage of Mg alloys is their low corrosion resistance. The presence of porosity  
adversely affects the corrosion resistance by enhancing the surface area exposed to the corrosive 
media [48]. In order to control the degradability of Mg scaffolds produced by powder metallurgy 
method, a multilayer polymeric matrix composed of polycaprolactone (PCL) and gelatin (Gel) 
reinforced with bioactive glass (BaG) particles has been coated on the surface of Mg scaffolds by 
freeze drying process [49]. In this study, Mg powder was mixed with carbonate hydrogen 
ammonium particles as the space holder agent with volume content of 35% and particle size of 
approximately 150±300 µm. The mixed powders were then pressed at a pressure of 400 MPa. 
Similar to other powder metallurgy techniques for production of Mg scaffolds, the burning out 
process was carried out at 175 °C followed by a 600 °C heat treatment for sintering. When the 
samples were immersed in a simulated body fluid for bioactivity tests, the Mg scaffold coated 
with PCL-BaG presented the best conditions for the deposition of biominerals. Both uncoated 
and Mg scaffold coated with the PCL-BaG entirely corroded after 3 and 7 days. However, 
approximately 87% of Mg scaffold coated with multilayer PCL-BaG/Gel-BaG coating remained 
intact after 14 days of immersion in A simulated body fluid (SBF) [49]. 
 
2.4. Hydrogen injection 
In hydrogen injection method, Mg melt is poured in a crucible under vacuum, and high pressure 
hydrogen is introduced into the chamber [50]. As demonstrated in figure 4, the melt is 
superheated in anticipation that the dissolved hydrogen reaches its saturation, and then it is 
solidified into a water-cooled copper mould. Accordingly, the melt is solidified upwards uni-
directionally and straight pores are formed by supersaturated hydrogen during solidification. 
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Changing the cooling part position would change the direction of pore growth [50]. Biological 
characterization on this type of Mg scaffolds by Gu et al. [51] indicated an acceptable corrosion 
rate and biocompatibility. However, there are some concerns about the absence of interconnected 
pores in the scaffolds made by this method of production. 
2.5. Laser perforation 
Laser perforation technique has been used to produce designed porous Mg scaffolds [11] since 
Mg has been known as a machinable metal. Porous Mg scaffolds can be developed by laser 
perforation system by means of a programmable multifunctional laser processing machine on the 
casted Mg ingots. The advantage of this method is the simplicity to control the structure, size and 
shape of pores. Normally, interconnected and homogeneous pores with round and honeycomb-
like structure can be formed by this technique [11]. Geng et al.  [11] produced a Mg scaffold 
with interconnected pores and honeycomb-like configuration. The optimum parameters in this 
study were the pulse frequency of 1-10 Hz, width of 0.3 ms, and the effective output of 100 W. 
Aligned long cylindrical pores with diameter of about 0.5 mm were manufactured within the Mg 
scaffold. The results confirmed a suitable behavior in mechanical properties due to the fewer 
flaws and voids resulting from the control of the fabrication technique [11]. Table 1 summarizes 
the techniques for producing porous Mg-based scaffolds. 
 
3. Biomedical coatings on magnesium scaffolds  
As aforementioned above, the main disadvantage of magnesium and magnesium alloy based 
scaffolds is their high corrosion rate, due to the high electrochemical activity of magnesium 
metal. Corrosion of magnesium alloy is rapid and inhomogeneous, as it can be localized 
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corrosion. The formation of hydrogen gas cavity due to the faster corrosion rate in comparison to 
the absorption rate is often observed in Mg scaffolds. In addition, an alkaline pH shift adjacent to 
the magnesium implant would result in damage to the host tissue. This has led to limiting the 
potential medical application of magnesium as implant, stents, and bone screws. Corrosion and 
degradation can drastically reduce the ultimate strength and fatigue life of implants. Increasing 
the surface area by introducing porosity generally increases the corrosion rates and accelerates 
the mechanical failure of the implant. To address the long-term safety of porous scaffolds, 
alloying and surface modification of magnesium scaffolds can be useful approaches. Altering the 
microstructure and composition by alloying, and surface modification of the scaffolds prior to 
the implantation, are conducted by a variety of materials and methods [16, 52, 53]. Surface 
modifying the scaffolds increases the corrosion resistance. The surface modification can be 
applied by two different processing techniques of conversion coatings or deposited coatings [27]. 
Conversion coatings are in situ chemical or electrochemical interactions of the magnesium 
scaffolds with the environment which leads to the formation of an inorganic ceramic-like coating 
on the surface. Deposited coatings are mostly organic coatings applied by different methods such 
as spraying, painting, spin coating, dip coating, or immersion. Materials used for coating should 
have specific characteristics such as good corrosion protection, biocompatibility, 
osseointegration, bioactivity, and controlled biodegradability. Hornberger et al. have 
comprehensively reviewed the different coating methods [27].  
Calcium phosphates (CaPs) with similar composition of the bone mineral component possess 
several beneficial properties such as excellent bioactivity and osteoconductivity for bone-graft 
applications [54]. Promoting new bone formation and developing strong interfacial bonding 
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between CaPs biomaterials and the host bone tissue makes this material an appropriate choice for 
surface modification of magnesium scaffolds.   
Hydroxyapatite [Ca10(PO4)6(OH)2, HA], one of different phases of the calcium phosphates 
(CaPs), has been investigated extensively. Surface modification by hydroxyapatite coating is an 
effective method for enhancing the corrosion resistance of magnesium scaffolds. Although 
hydroxyapatite has exceptional biocompatibility, bioactivity properties, and similar chemical and 
structural nature as bone, it suffers from high brittleness and low strength which limits its 
application in load bearing conditions [55]. Therefore, utilizing biodegradable magnesium 
scaffolds with appropriate mechanics, coated with hydroxyapatite to enhance corrosion 
resistance, and to enhance bone forming ability can be a promising scaffold for bone tissue 
engineering in load bearing applications [56]. Different techniques such as sputtering 
process, electrophoretic deposition, sol±gel process, and biomimetic deposits can be used to coat 
metallic surfaces by hydroxyapatite. However, due to the poor heat resistance of magnesium, 
none of these techniques can be used efficiently for hydroxyapatite coating of magnesium 
scaffolds since a high temperature treatment will be required to densify the coating [56]. 
Therefore, one of the promising options to surface modify magnesium scaffolds is using 
electrochemical deposition which includes low deposition temperature and is capable of creating 
uniform coatings with controlled thickness and chemical composition [56-58].  
Hydroxyapatite crystal structure size and morphology can also be manipulated by electrolyte 
concentration and electrochemical potential. Recently, researchers found that the morphology of 
hydroxyapatite coating can affect its osteoconductivity and biocompatibility. Healing process of 
bone defects can be accelerated by loose hydroxyapatite coating which allows easier infiltration 
and ingrowth of new bone tissue. [57-59].  
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One of the main concerns of using magnesium scaffolds is the amount of Mg ions and hydrogen 
gas released by its corrosion. Incorporating Zn element in contents of less than 3% can improve 
the corrosion resistance [60] and the mechanical properties of magnesium scaffolds [56, 61]. 
Seyedraoufi et al. [59] investigated and optimized different parameters of pulse electrodeposition 
such as peak current density, temperature, and duty cycle to surface modify porous Mg-2wt.% 
Zn scaffolds with nano hydroxyapatite (Ca10(PO4)6(OH)2) coating upon post-treatment in alkali 
solutions. Porous Mg-2Zn (wt.%) scaffolds were prepared using a powder metallurgy process. 
Under optimized pulse electrodeposition of 1 hour, 40 mA cm-2 peak current density, 85 ºC 
temperature, and 0.1 duty cycle, followed by post-treatment in alkali solutions, uniform nano 
hydroxyapatite coatings were generated on the scaffolds. As shown in figure 5, perpendicularly 
needle-like hydroxyapatite crystals with 2-3 µm length with less than 100 nm in diameter were 
created on the surface of the scaffolds. Loose needle-like hydroxyapatite crystals highly 
resemble the inorganic apatite structure of natural bone [59]. 
Tricalcium phosphate [Ca3 (PO4)2, TCP] as coating material exhibits desirable biocompatibility 
and bioactivity. However, TCP shows poor mechanical strength and crack-growth propagation 
resistance. In contrary to HA which has poor rate of biodegradability, TCP is biodegradable. 
7&3KDVWKUHHSRO\PRUSKVDQGDPRQJWKHPȕ-TCP with hexagonal crystal structure and R3CH 
space group has a slow-degrading rate [62] ,Q DGGLWLRQ ȕ-TCP shows desired 
osteoimmunomodulatory properties which activates the immune response leading to accelerated 
bone healing process. Favorable osteoimmunomodulatory properties adjust the balance between 
osteogenesis and osteoclastogenesis which improve bone regeneration.  Chen et al. prepared [63] 
magnesium scaffolds with the laser perforation technique and coated theP ZLWK ȕ-TCP, in an 
DWWHPSWWRH[SORLWWKHDGYDQWDJHVRIȕ-TCP coating such as osteoconductivity, biocompatibility, 
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high chemical stability, slower degradation rate compared to magnesium, and 
osteoimmunomodulatory [63] ,Q WKLV VWXG\ WKH LPSRUWDQFHRIȕ-TCP coating in immune cells 
and bone cells response was emphasized, and the role of immune cells in adjusting osteogenesis 
and osteoclastogenesis balance was LQYHVWLJDWHG 2VWHRLPPXQRPRGXODWRU\ SURSHUW\ RI ȕ-TCP 
coating demonstrated the activated M2 phenotype of macrophage and release of bone 
morphogenetic protein 2 (BMP2). Subsequently,  osteogenic differentiation of bone marrow 
stromal cells was observed due to the presence of  BMP2 [63, 64]. Activated macrophages 
secrete BMP2 and transforming growth factor b (TGF-b). It has been shown that the discharging 
macrophages result in the inhibition of in vivo bone formation [65-68]. Thereby, magnesium 
VFDIIROGV FRDWHG ZLWK ȕ-TCP showed desired osteogenesis over osteoclastogenesis, due to the 
upregulDWLRQ RI RVWHRLQGXFWLYH PROHFXOHV VHFUHWHG E\ PDFURSKDJHV LQ FRQWDFW ZLWK ȕ-TCP 
coating [63].  
In a similar study, Geng et al. manufactured [69] interconnected porous magnesium scaffolds 
XWLOL]LQJ ODVHU SHUIRUDWLRQ WHFKQLTXH DQG FRDWHG WKH VDPSOHV ZLWK ȕ-TCP [69]. In vitro 
biodegradation mechanism of surface modified scaffolds was evaluated and the osteosarcoma 
cell (UMR106) attachment and proliferation were studied. Figure 6a shows a macrograph of a 
fabricated porous magnesium scaffold with cylindrical aligned pores with 48% porosity before 
surface modification. Figure 6b is a 6(0 LPDJH RI WKH ȕ-TCP coated scaffolds obtained by 
chemical process of immersion in the mixture of Ca(NO3)2 and Na2HPO4.12H2O after alkali-heat 
pretreatment.  
Comparing the pH change of uncoated magnesium scaffold with coated scaffolds incubated in 
FHOOFXOWXUHPHGLXPLQGLFDWHVWKDWWKHS+RIWKHȕ-TCP coated scaffolds was similar to the pH of 
the control group, while the uncoated scaffolds have significantly increased pH value. This result 
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confirms tKHEDUULHUSURSHUW\RIȕ-TCP which increases the corrosion resistance of the scaffold 
and decreases the magnesium ion release, and control the pH of the medium [69],QDGGLWLRQȕ-
TCP coating acts as reservoir of calcium and phosphate ions around the scaffolds and triggers the 
bone growth. It has been reported that the local supersaturation of the body fluid with calcium 
and phosphate ions enhances the growth of bone [70, 71].  
'HJUDGDWLRQRIȕ-TCP coating on the magnesium scaffold is coincident with the regrowth of new 
calcium and phosphate coating on the surface. This effect occurs by two simultaneous 
mechanisms namely increased QXFOHDWLRQDQGLQFUHDVHRIS+YDOXHV)LUVWGHJUDGDWLRQRIȕ-TCP 
increase the magnesium ions release, which in turn leads to an elevated calcium concentration 
that is desired for nucleation and growth of the Ca-P compound on the magnesium scaffold [69, 
72-74]. Concurrently, enhanced ionic activity of apatite at higher pH, due to the degradation of 
magnesium, can increase the apatite nucleation and formation of new Ca-P coating [75]. 
In an attempt to decrease the degradation rate and to increase the possible application potential of 
magnesium scaffolds in the field of tissue engineering, further biomedical coating studies have 
investigated various biodegradable materials such as polycaprolactone (PCL) [47, 76], 
polycaprolactone-bioactive glass (PCL-BaG) [40], and gelatin-bioactive glass/polycaprolactone-
bioactive glass (Gel-BaG/PCL-BaG) coatings [49]. The results showed drastic enhanced 
corrosion resistance and compressive strength during the immersion in physiological saline 
solution (PSS). The open porous magnesium scaffolds were manufactured by a powder 
metallurgy technique. While the uncoated scaffolds degraded completely and lost 100% weight 
after 72 h, coated scaffolds with 3% w/v and 6% w/v PCL showed 36% and 23% weight loss, 
respectively. In addition, 41% and 83% improvement in compressive strength, and 24% and 
100% enhancement in the elastic modulus have been observed, respectively, in 3% w/v and 6% 
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w/v PCL coated magnesium scaffolds [47, 76]. In addition, incorporating bioactive glass (BaG) 
into the coating layer led to improved bioactivity and mechanical integrity compared to the 
uncoated scaffold. Formation of an apatite layer on surface modified scaffolds was observed 
after immersion in SBF, which should stimulate biological bone ingrowth and prevent micro-
cracks and pore channels propagation [40]. In the next step, utilizing a freeze drying process, 
gelatin (Gel)-bioactive glass (BaG) porous layer was added on top of the PCL-BaG layer of the 
porous magnesium scaffolds. As shown in the SEM images of figure 7, porous structure of 
magnesium scaffolds, PCL-BaG inner layer coating, and Gel-BaG outer layer are distinguishable 
from each other. While the Mg scaffold/PCL-BaG/Gel-BaG coating almost remained intact after 
14 days in SBF, the non-coated Mg scaffold was fully degraded after 3 days and Mg 
scaffold/PCL-BaG was fully degraded after 7 days.  In conclusion, the Mg scaffold with PCL-
BaG/Gel-BaG coating showed better bioactivity, higher mechanical integrity and corrosion 
resistance compared to other scaffolds [49]. 
 
4. General properties and evaluations techniques  
4.1. Mechanical properties  
An appropriate mechanical strength and stability is required for scaffolds being used in 
musculoskeletal tissue engineering. Among all possible candidates, magnesium alloys attract 
considerable attention due to their desirable mechanical and biodegradation properties. During 
the last decades, researchers have shown increasing interest towards magnesium as a potential 
biodegradable material for bone and cartilage tissue engineering [29, 40]. In terms of mechanical 
properties, magnesium alloys show better characteristics than biodegradable polymers such as 
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polyglycolic acid (PGA) or polylactic acid (PLA). Furthermore, degradation and 
biomineralization of bioactive materials on the surface on the magnesium scaffolds promote 
osteoblastic activity and ingrowth of the new tissue [35, 45]. 
Cancellous bone is an interconnected porous structure with porosity varying within the range of 
30% to 95%. It is well known that inclusion of porosity into the implants to make the scaffolds, 
can increase the similarity to the bone structure and enhance the ingrowth of new tissue, 
however, it can also compromise the mechanical properties. Scaffolds must have adequate 
strength and stiffness to tolerate the physiological loads. The main concern about the use of 
PHWDOOLFLPSODQWVVXFKDVPDJQHVLXPDOOR\VLVWKHPLVPDWFKRI<RXQJ¶Vmoduli of the implants 
and the adjacent bone tissue. This inconsistency between mechanical properties results in the 
inadequate loading of the bone that leads to  bone stress shielding, can subsequently cause bone 
resorption, implant loosening, formation of cracks within the implant, and implant migration [77-
80]. Thus, implants should have appropriate strength and stiffness matching those of bone tissue. 
By changing the material of the implant, one can achieve optimal elastic moduli close to the 
bone to prevent stress shielding. When stress shielding is reduced by changing the material, 
stiffness mismatch can still exist. In order to overcome the stiffness mismatch, researchers have 
made porous implants (scaffolds).  Porous materials have reduced stiffness mismatches and 
increased the tissue scaffold interaction by bone ingrowth which helps in the fixation of implants 
in their place [16]. However, it is noteworthy to mention that the scaffold suffers from drastic 
decreases in fatigue strength.    
It has been observed that the production method of porous magnesium can affect the mechanical 
behavior and the collapsing mechanism of the sample. A short elastic deformation in the initial 
stages of the stress-strain curves of compressive loading has been observed in specimens 
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produced by the mechanical perforation method [81] and by melt casting [42]. This behavior 
indicates the bulk deformation of scaffolds under the compression load, however, porous 
magnesium specimens produced by metal foaming method [82] and powder sintering method 
[48] show local collapse of pores with shortened elastic deformation. Following the linear elastic 
deformation ending at the yield strength, normally magnesium samples exhibit a long plateau of 
constant stress [82].  
Changing the pore size, pore shape, porosity, and pore distribution can affect the mechanical 
properties [48, 83, 84]. Increasing porosity results in the decrease of compression strength, yield 
VWUHQJWK DQG <RXQJ¶V PRGXOXV [48, 83, 84]. The mechanical properties of porous magnesium 
prepared by the green compacts method using carbamide particles as the space holder and under 
100 MP uniaxial pressure were studied to demonstrate the dependence of mechanical properties 
on pore size and porosity [48]. Scaffolds with pore size of 70±400 µm and porosity of 35±55% 
were prepared. Compressive strength tests showed a decrease in compressive strength and 
<RXQJ¶VPRGXOXVZLWKLQFUHDVHLQSRURVLW\DQGSRUHVL]H6FDIIROGVZLWKSRURVLW\DQGSRUH
size of 250 µm demonstrated 1.8 GPa of <RXQJ¶V PRGXOXV DQG  03D SHDN VWUHVV DQG
scaffolds with pore size of 73 µm and porosity of 45% showed 1.3 GPa of <RXQJ¶VPRGXOXVDQG
16 MPa peak stress. Considering the mechanical properties of cancellous bone with compressive 
VWUHQJWKDQG<RXQJ¶VPRGXOXVRI±80 MPa and 0.01±2 GPa [85],  mechanical properties of 
porous magnesium fall in the range of cancellous bone which makes this material a suitable 
option for hard tissue regenerative scaffolds . 
 
4.2. Bio-corrosion behavior 
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In contrast to inert materials such as PLA, the increase in bone formation and decrease in healing 
time observed with magnesium implants indicates the potential osteoconductivity and bioactivity 
of magnesium [29, 35]. The Osteoconductivity of magnesium is induced by the precipitation of 
calcium phosphate on the surface of the implants in an in vitro environment due to corrosion [86, 
87]. Biomimetic calcium phosphate coatings enhance osteoblast response, impart 
osteoconductive capacity, and reduce the healing time for bone defects. Moreover, enhanced cell 
attachment and ingrowth due to calcium phosphate precipitation can lead to reduced corrosion 
rate [29].  
Exposing pure magnesium to air will result in the formation of a gray oxide film of magnesium 
hydroxide on the surface. Recent studies [31, 34, 49, 88-95] proposed the formation of 
magnesium hydroxide and release of hydrogen bubbles in the electrolytic physiological 
environment upon degradation of magnesium, through the oxidation and reduction reactions 
which are summarize in the following reactions: 
 
Oxidation reaction (?(?(?0Jĺ0J2 ++2eí  
5HGXFWLRQUHDFWLRQ(?(?(?2H2 O+2eíĺ+2 (g)+2OH í  
Combination reaction: Mg2 ++2OHíĺ  Mg(OH) 2  
 
Magnesium hydroxide is not highly soluble in water.  The reaction between magnesium 
hydroxide and chlorine ions from the tissue fluid or any simulated biological fluids leads to 
production of highly water soluble magnesium chloride. The release of hydroxide ion from 
magnesium hydroxide upon reaction with chlorine ions results in the local enhancement of the 
pH value near the host tissue. The presence of calcium and phosphate ions in the tissue fluid 
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triggers the production of MgxCay(PO4)z(OH)n compounds, such as calcium phosphate and/or 
calcium magnesium phosphate by the interaction between Mg2+, Ca2+, and PO4í. These complex 
bioactive mineral products form a deposition layer on the surface of magnesium scaffolds and 
inhibit further corrosion and increase of pH value. It has been shown that degradation, and 
consequently deposition of the bioactive passive layers containing calcium, promotes osteoblast 
growth [96, 97]. 
 
4.3. Cell/scaffold interactions 
For newly designed materials, cytotoxicity tests including extract based assays, direct contact, 
and indirect contact for investigating the cell-scaffold interaction, are conducted by applying 
International Organization for Standardization (ISO) standards 10993-5 and 10993:12. Although 
direct contact cell cytotoxicity methods may introduce additional information, extract based 
assays are the most common ones [98]. These cytotoxicity testing standards are developed for 
non-degradable materials, thus applying them on the degradable magnesium scaffolds may not 
be suitable. Upon immersion of pure magnesium inside the extraction medium, visible gas 
evolution is detectable. Strong degradation locally increases the pH value which is evident by 
tuning normally red medium to colorless medium by the deprotonization of the phenol red. 
Rapid degradation of magnesium scaffolds in aqueous environment and cell culture media 
produces highly concentrated extracts with magnesium, strong hydrogen production, very high 
osmolalities and pH-values.  
Osmotic shock by this harsh environment can be lethal to the cells in vitro and makes the in vitro 
cell culture evaluation nearly impossible for magnesium scaffolds with ISO standards. Active 
transport processes in in vivo environments regulate most of these fluctuations. Therefore, most 
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research groups bypass the in vitro tests for magnesium scaffolds and directly perform in vivo 
animal tests, which may be problematic from an ethical point of view. In order to address these 
issues one can use an in vitro bioreactor with dynamic flow system to simulate the human body 
situation. However, bioreactors are not always available and the need for in vitro experiments for 
magnesium scaffolds can be addressed by establishment of reliable test systems. Fischer et al. 
[99] proposed that in vitro cytotoxicity tests  for magnesium materials must be done under 
physiological conditions corresponds to in cell culture medium containing 10% fetal bovine 
serum. A physiological condition is a CO2 level of 5%, an O2 level of 20%, temperature of 
37 °C, and relative humidity of 95%. As proposed, 10 times more extraction medium should be 
used comparing to the recommended volume by the ISO standards (EN ISO standards 10993:5 
and 10993:12 suggest specimen weight to extraction medium to be 0.2 g/mL) to have reliable 
results for cytotoxicity [99]. Dilution of the pure extracts decreases the osmolality and high 
magnesium concentration to avoid cell cycle arrest or apoptosis. It is noteworthy to remember 
that a high dilution may eliminate most toxic ionic content from the extracts and prevent real 
cytotoxicity evaluation. On the other hand, cytotoxicity studies on biodegradable magnesium 
scaffolds by the tetrazolium-salt-based assays such as MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide) and XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
((phenylamino)carbonyl)-2H-tetrazolium hydroxide) are prone to  experimental errors. Corroded 
magnesium can interact with tetrazolium salts and convert it to formazan, causing misleading 
results in static in vitro assays.  Therefore, using these assays should be conducted with high 
level of caution. It is suggested [100] to use luminescence-based (BrdU) cytotoxicity assays 
which do not have any interference with the corroding magnesium. 
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In vitro studies of biodegradable open porous magnesium scaffolds confirmed the different 
response of human osteoblast cells (HOB) and fibroblastic cell line (L929) to osmotic and ionic 
changes. HOB showed better survival in higher osmotic solutions but exhibited lower 
proliferation rate comparing to L929 cells in high osmotic extracts [101]. This behavior may be 
explained by the cell-type-dependent proliferation to cell volume. Cell proliferation can be 
altered by osmotic swelling or shrinkage. Osmotic swollen cells exhibit more cell proliferation 
compared to osmotic shrunk cells.  Osmotic shrunk cells demonstrate inhibited or delayed cell 
proliferation in hyperosmotic solutions [102]. 
 Zhang et al. Showed extracellular magnesium ions have regulatory effects on intracellular free 
ionized calcium ([Ca2+]i) [103]. Magnesium ions can affect the [Ca2+]i and K+ channels. It was 
confirmed that [Mg2+]o regulates the level of [Ca2+]i and modulate cell shapes and metabolism of 
cultured vascular smooth muscle cells to control vascular contractile activities. It is known that  
[Ca2+]i concentration can critically change the cell cycle, and K+ and Cl- channels can influence 
cell proliferation and cell cycle progression [101-104]. By having these facts in mind and 
considering the release of magnesium ions upon corrosion of the scaffold, one can correlate the 
effect of excess magnesium ion inside the extracts and the cell cycle arrest or apoptosis.  
Selective interaction of magnesium ions with each type of cell culture media extracts can change 
the behavior of the magnesium ions, resulting in distinct cytotoxicity responses for different cell 
types. For instance, corrosion of magnesium scaffolds in RPMI-1640 +10% FBS and DMEM 
+10% FBS showed similar degradation rate under the same cell culture conditions. However, 
significant differences in magnesium ion concentrations in two extracts were observed [101]. 
Both original cell culture media, namely RPMI-1640 +10% FBS and DMEM +10% FBS, have 
similar magnesium ion concentration and protein content.  The difference in magnesium ion 
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concentration between two media can be explained by the higher concentration of L-glutamine 
amino acids in DMEM, which can create complexes with magnesium [101].  
 
4.4. In vivo assessments 
The host tissue interaction with scaffolds, the fate of the biodegradable scaffolds, the ingrowth of 
newly formed tissue, in addition to neoangiogenesis, and inflammatory response, are important 
aspects of tissue engineering which should be considered for each scaffold designed for a 
specific application. 
Three distinct phases have been recognized for the host tissue interaction with biodegradable 
scaffolds. The first phase occurs within the first two weeks of implanting the scaffolds and it is 
mainly characterized by the initiation and development of an inflammatory host response. This 
response is basically independent of the degradation rate of the scaffolds. This early phase 
response is indicated by the presence of plasma cells, lymphocytes, polymorphonuclear 
leukocytes, and monocytes. The second phase is detected by the predominance of monocytes and 
their differentiation to phenotype of macrophages, fibrous tissue encapsulation of the implants 
and neo-angiogenesis. The length of the second phase is determined by the rate of 
biodegradation of the implanted scaffolds. Increase in the degradation time would increase the 
length of the second phase. In addition, the presence of the foreign body giant cells at the surface 
of the scaffolds is evident in the second phase by fusion or joining the macrophages 
together. The third phase starts following the last steps of the degradation of the scaffold when 
the scaffold loses its integrity and mechanical properties. The formation of a fibrous capsule is 
accelerated in the third phase. In this step, the scaffolds totally lose their mechanical properties 
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and the newly formed tissue replaces the scaffold. The scaffolds breakdown into particles, which 
undergo macrophage phagocytosis [105].  
As mentioned above, magnesium is naturally found in bone and it is the fourth most abundant 
cation in the human body [106]. Witte et al. studied the behavior of host tissue response to open 
porous magnesium alloy AZ91D scaffolds during 3 and 6 months of implantation. Figure 8 
shows the experimental design and porous scaffold prepared by casting in a negative salt pattern 
molding.  
Although 2 weeks after the implantation gaseous bubbles were observed nearby the rabbit knees, 
all these bubbles disappeared within 1 week. No adverse events such as body weight loss, 
abnormal behavior, inflammation, damage to neighboring tissues, enhanced cell infiltrate into 
scaffold site, osteolysis, and sterile sinuses were detected. Chloracetatesterase histochemistry 
was used for detecting neutrophile granulocytes, which represent the initial stage in 
inflammatory response, and no significant inflammatory processes were observed for magnesium 
scaffolds. Healing happens in 3 consequent stages of formation of fibrous capsule, angiogenesis, 
and bone formation.   Fibrous capsule formation, which was accompanied with newly formed 
blood vessels, and later bone formation and ingrowth into the degraded scaffolds were detected 
in Mg and Mg alloy scaffolds.  New bone formation at the interface of magnesium scaffolds due 
to osteoconductive properties advocates the fibrosis elimination and complete replacement with 
new bone tissue in later stages of the healing process [45]. Biomineralized bone volume detected 
by von Kossa stain in the vicinity of the degrading magnesium scaffolds revealed significantly 
higher density of bone growth comparing to the control side. This is suggested to be due to the 
increased osteoblastic and osteoclastic activities in the proximity of the degrading magnesium 
scaffold which resulted in formation of more mature bone structure. Compared to the control 
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site, reduced trabecular separation and higher trabecular number were observed, indicating 
formation of a more mature bone with a superior mechanical properties and osseointegration 
process [107, 108]. 
Liu et al. [89] studied the in vivo biodegradability and osteogenicity of porous magnesium 
scaffolds by implantation inside the femoral condyle of male New Zealand white rabbits [89]. 
Porous magnesium scaffolds were prepared by machining the extruded pure magnesium bars and 
surface modified by microarc oxidation technology. Histological examination on the heart, 
kidney, spleen, and liver exhibited normal morphology, confirming good biocompatibility of the 
both porous magnesium scaffold and control scaffolds. However, significant differences in 
degradation and new bone formation between magnesium scaffolds and control scaffolds were 
detected. This has been confirmed by micro-CT scans of 3 months post-operation scaffolds 
(figure 9). [89]. 
It is noteworthy to mention that in the X-ray images of the magnesium scaffold, bubbles 
appeared around the implanted scaffolds after 2 weeks due to the degradation of magnesium and 
formation of hydrogen gas. Although surface modifications was used to reduce the degradation 
rate and to decrease hydrogen generation, formation of mild swelling in rabbits knees starting 
from 2 weeks and persisting for 2 months, indicated inadequate thickness of magnesium oxide 
and surface treatment [89]. However, these findings show that even fast degrading magnesium 
scaffolds demonstrate good biocompatibility, suitable inflammatory response, and bone 
regeneration, which makes open porous magnesium scaffolds good candidates for bone and 
cartilage tissue engineering [45]. 
 
5. Applications 
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5.1. Bone 
One of the most important advantages of the biodegradable magnesium scaffolds over 
conventional permanent metal scaffolds is total in vivo corrosion of the scaffolds and elimination 
of the additional surgery step of scaffolds removal. This will help to reduce the health risks,  
costs, and improve the patient compliance [47, 99, 101]. 
In long term applications such as bone implants, the magnesium scaffold must have slow rate of 
degradation to allow cell proliferation and ingrowth. Increased surface area in porous scaffolds 
leads to an increase in the corrosion rate. To control the degradation rate in such application, 
magnesium alloys are prepared. Incorporating yttrium to magnesium can increase the corrosion 
resistance. It is well known that yttrium element stimulates the grain refinement, increases 
cytocompatibility, and reduces the corrosion rate of magnesium [109-111]. Bobe et al. added 4 
wt.% yttrium to magnesium and made open porous scaffolds by liquid phase sintering technique 
using magnesium short fibers [101]. As shown in the figure 10a, fibers with a diameter of 100-
250 µm and a length of 4±8 mm under argon atmosphere were manufactured utilizing crucible 
melt extraction technique. Deposition of fibers on a tantalum substrate with an MgO sieve, with 
further liquid phase sintering, and subsequently additional heat treatment produced a bulk porous 
material which was finally cut into cylindrical porous scaffolds as shown in figure 10d. Light 
microscopy determined 58 to 63% porosity for the scaffolds. Mechanical analysis of the prepared 
VFDIIROGV VKRZHG <RXQJ¶V PRGXOXV ZLWKLQ WKH UDQJH RI KXPDQ FDQFHOORXV ERQH DQG
compression strength exceeding that of human cancellous bone.   
In vivo implantation of open porous scaffolds in femoral condyle of female rabbits demonstrated 
no severe clinical signs of gas cavities or inflammation. In general, rabbits showed normal 
foreign body giant reaction towards the implanted scaffolds with no pathological changes in the 
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histology of the internal organs including lung, liver, pancreas, kidney, heart, spleen, and 
intestine or any blood abnormalities. In addition, no signs of necrotic tissue or fibrous 
encapsulation were found at 6 weeks or at 12 weeks after implantation. Moreover, osteoblasts 
and osteoclast cells remodeling bone around and inside the scaffold were observed at 6 and 12 
weeks respectively. However no signs of gas cavities were detected clinically. Postoperative 
microtomographs (figure 11) showed some entrapped gas cavities after 6 weeks around the 
implanted scaffolds. These gas cavities demolished within 12 weeks. Slow in vivo scaffold 
degradation and almost intact scaffolds after 6 weeks were detected by microtomography. Figure 
11b shows evidence of new bone formation adjacent to the scaffolds. Slow in vivo scaffold 
degradation proceeds to 12 weeks and at this time only 7% volume of the scaffold remained.  
 
5.2. Cartilage 
Hyaline articular cartilage tissue lacks the sufficient regenerative potential due to absence of 
blood vessels in their structure. Therefore, all required nutrition agents and growth factors are 
being transferred by diffusion from the bone marrow and remote blood vessels. Cartilage 
nutrition is supported by the subchondral bone plate, thus any damages such as osteochondral 
defects can prevent regenerating cartilage. In such cases, using a biodegradable scaffold as the 
subchondral bone plate can enhance the cartilage healing process [112-114]. Ideal scaffolds in 
subchondral bone plate tissue engineering should provide adequate mechanical stability, 
appropriate pore size, sufficient porosity, and optimized programmed degradation. Gradual 
degradation provides more space for ingrowth of new tissue and blood vessels [47, 115-117].  
The degradation profile of scaffolds for cartilage repair should warrant two months of suitable 
mechanical integrity, and afterwards rapid degradation to allow the infusion of nutrition and 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
29 
 
reparative cells towards the healing site. Magnesium scaffolds were studied as the subchondral 
bone plate to induce cartilage repair [118]. Magnesium alloy (AZ91) with 75% porosity showed 
rapid degradation at twelve weeks postoperatively. Although no signs of negative influence were 
detected at the adjacent cartilage tissue, no adequate subchondral bone plate regeneration was 
observed. Furthermore, histological studies showed no significant cartilage regeneration above 
the degraded magnesium scaffold. Similar results have also been observed using autografted 
cancellous bone as the replacement of the subchondral bone plate [118]. This finding is 
surprising since the autograft is believed to be the best and first option for regenerative tissue 
engineering due to its immunocompatibility. Application of autografts is mainly limited by 
inadequate availability, and donor bone site morbidity [119, 120]. Comparison studies using 
autografted cancellous bone  and magnesium scaffold for osteochondral defects confirm the 
necessity for the unconstrained access to nutrition and reparative cells from the bone marrow 
[118, 120]. Therefore, the designed scaffolds should satisfy the need for local blood circulation 
and bone marrow accessibility. On the other hand, in the untreated osteocartilage defect with the 
highest accessibility to bone marrow cavity, no reproduction of subchondral bone in the central 
part was observed [118]. Magnesium scaffolds with optimal porosity should provide appropriate 
mechanical support [47, 48], osteoinductive properties, excellent biocompatibility [121], 
biodegradability and bioresorbability [122]. Thus, such scaffolds can be designed to be suitable 
candidates for subchondral bone plate replacement. 
 
6. Conclusion and future work 
Porous scaffolds for biomedical applications such as orthopedic reconstructive surgery continue 
to attract research attention, which is confirmed by the ever-increasing number of publications on 
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this subject. Metallic biomaterials have great potential as the basic materials to develop such 
scaffolds, especially for load-bearing applications due to their high mechanical properties 
compared to biodegradable polymeric materials. Recently introduced Magnesium and its alloys 
appear to have the potential to be suitable biodegradable metallic materials with similar 
mechanical properties as those of bone. Mg and Mg alloys have shown encouraging results when 
used as tissue engineering scaffolds. This review summarized the common methods for 
fabricating porous Mg-based scaffolds. It also explored some of the surface modification 
methods, biological performance, and applications of Mg-based scaffolds. While a considerable 
number of studies encourages the use of magnesium alloys in bioactive and biodegradable 
implants for load bearing orthopedic applications, a great deal of research is still essential to fully 
assess the in vivo long-term capability of such scaffolds. The possibility of magnesium being 
employed as a reliable metallic scaffold calls for persistent research and study on in vitro 
osteoblast cell attachment, proliferation, differentiation to an osteoblast phenotype, formation of 
a bone matrix, studies of bone apposition, tissue regeneration, and finally in vivo bone healing 
including introduction of angiogenesis. In fact, the application of biodegradable metallic 
scaffolds for tissue engineering purposes is just at the beginning. Controlling the degradation rate 
of magnesium in body fluids can be the first step to advance the field, which may be achieved 
through the use of alloying elements, casting and forming techniques, composite fabrication 
and/or surface coatings. The possible cytotoxicity of the modified systems will also require 
further verification. A great deal of research is still needed to develop superior, straightforward, 
and more cost-effective modification methods to facilitate the full use of the biodegradability, 
mechanical strength, and improved bio-functional properties of Mg alloys. In addition, rapid 
prototype methods could be considered to produce porous scaffolds with properties purposely 
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tailored for the cell regeneration and the tissue in-growth. Future research directions include 
understanding the effect of porosity on the corrosion and mechanical properties, the cell 
regeneration and tissue healing in the porous structure, developing procedures for manufacturing 
suitable porous Mg scaffolds, and finally control over the degradation rate of the scaffolds. 
Furthermore, integrating Mg scaffolds with biopolymers, bioactive ceramics and drugs 
represents a new promising path to investigate. 
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Figure Captions  
Fig.1. Schematic design of the titanium wire space holder method for the production of porous 
magnesium scaffold (reproduced with permission of (42)) 
Fig. 2. Schematic picture of the negative salt pattern molding process: (a) polymeric template produced 
by rapid prototyping, (b) infiltration of produced porous polymer with salt paste, (c) Burning the polymer 
template and sintering of salt template, (d) casting of Mg melt into the produced salt template, and (e) 
final porous Mg scaffold following salt removal (reproduced with permission of (45)) 
Fig. 3. The cross section of Magnesium scaffold produced by powder metallurgy (reproduced with 
permission of (48)) 
Fig. 4. Schematic representation of the hydrogen injection technique through the Mg melt (reprinted with 
permission of (51)) 
Fig. 5. SEM micrographs in the different magnifications of perpendicularly needle-like hydroxyapatite 
(reprinted with permission of (60)) 
Fig.6. (a) Porous magnesium scaffold prepared by laser perforation technique before coating. (b) SEM 
PLFURJUDSKRIWKHȕ-TCP coated scaffolds (reproduced with permission of (71)) 
Fig.7. (a,b) low and high SEM magnification of magnesium scaffold. (c,d)  top and cross-sectional view 
of magnesium scaffold coated by PCL-BaG layer. (e, f) cross-sectional view of magnesium scaffold 
coated with PCL-BaG inner layer and outer layer of Gel-BaG.  (g) Inside and (h) top view of coated 
scaffold (reprinted with permission of (50)) 
Fig.8. (a) Magnesium alloy AZ91D cylindrical porous scaffold. Red rectangle in the middle picture shows 
the scaffold insertion place into right knees.  (b) A special pestle used for boreholes insertion. Left knees 
were used as controls.  Blue circle shows the autologous bone grafted from the left patellar grooves. The 
empty patellar defect works as a control for natural defect remedial. (c,d) Longitudinal sections of 
safranin-O stained for magnesium scaffold site and the autologous patellar grooves bone site show the 
development of the wound healing six months postoperatively. Black arrows show the leftovers of the 
cartilaginous surface of the reverse implant. (e) Transversal section of safranin-O stained patellar defect. 
Scale bar ¼ 2000 µm (a), 500 µm (c, d, e) (reprinted with permission of (46)) 
Fig.9. Micro-CT image of (a) magnesium scaffold and (b) hydroxyapatite scaffold as control group.  The 
new bone tissue in-growth is shown in green color (reprinted with permission of (91)). 
Fig.10. (a) Melt extraction procedure to manufacture short fibers. (b) Deposition of Mg alloy fibers onto a 
moving substrate with an MgO barrier, then sintered and cut by laser jet method. (c) SEM cross sections 
of fibers demonstrates the sinter bonds (bar = 20 µm). (d) Cylindrical scaffolds before in vitro or in vivo 
tests (bar = 1000 µm). (e) SEM image of scaffold surface (bar = 200 µm) (reprinted with permission of 
(103)) 
Fig.11. (a) Tomograms of scaffolds before the implantation show open inter-connected porous structure 
with no residual materials. (b) At 6 weeks, newly formed bone marked by white dots, and gas cavities 
showed by white star.  (c) 12 weeks no gas cavity is detectable. (White arrow heads indicates metallic 
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implant and black arrow heads show corroded parts)  (Scale bar = 1 mm) (reprinted with permission of 
(103)) 
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Production methods Advantages Disadvantages References 
Titanium wire space holder 
-Adjustable pore size and structure 
-Pipe-like pore structure  
-The use of hydrofluoric acid for 
etching off the titanium wires  (42) 
Negative salt pattern molding 
-Controllable porosity and microstructure 
-Topologically ordered porosities 
-Casting equipment (44, 46) 
Powder metallurgy 
-Interconnected pores 
-Easy technique  
-Lack of acceptable mechanical 
integrity and corrosion resistance  (47-50) 
Hydrogen injection -Upwards unidirectional and straight pores -Casting equipment (51, 52) 
Laser perforation 
-Simple to control the structure, size and shape 
of pores 
-Interconnected and homogeneous pores with 
round and honeycomb-like structure 
-Programmable multifunctional laser 
processing machine (27) 
Table 1: Summary of the Mg scaffold production methods, their advantages and disadvantages 
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Highlights 
x There has been much effort on the development and characterization of metal implants  
x A porous 3D material provides the required pathways for cells to grow, proliferate, and 
differentiate 
x Porous magnesium and Mg alloys are good candidates to serve as a biodegradable 
scaffold for bone treatments 
x This review aims to bring together recent studies on Mg and Mg alloys scaffolds with 
regards to production techniques, surface modifications, general properties, potential 
applications and future trends 
